Compare ARYX to:
After Hours: 2.7095 N/A (N/A) 1:17pm ET
| Last Trade: | 2.71 |
|---|---|
| Trade Time: | Nov 27 |
| Change: | |
| Prev Close: | 2.81 |
| Open: | 2.81 |
| Bid: | N/A |
| Ask: | 3.58 x 1000 |
| 1y Target Est: | 6.38 |
| Day's Range: | 2.70 - 2.82 |
|---|---|
| 52wk Range: | 1.75 - 6.32 |
| Volume: | 36,620 |
| Avg Vol (3m): | 73,647.7 |
| Market Cap: | 74.76M |
| P/E (ttm): | N/A |
| EPS (ttm): | -1.54 |
| Div & Yield: | N/A (N/A) |
| Wed, Nov 18 | ARYX THERAPEUTICS, INC. FinancialsEDGAR Online Financials |
| Wed, Nov 18 | Results From Phase 2b Study on Atrial Fibrillation Agent Reviewed at American Heart AssociationBusiness Wire |
| Sun, Nov 15 | New Star Analyst Rankings for ARYx Therapeutics, Inc.StarMine |
| Fri, Nov 13 | ARYX THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online |
| Thu, Nov 12 | Aryx Therapeutics reports $8.2M lossat bizjournals.com |
| Thu, Nov 12 | Third Quarter 2009 Results and Earnings Call scheduled for 11:00 am ET todayShareholder.com |
| Thu, Nov 12 | ARYx Therapeutics Reports Third Quarter 2009 ResultsBusiness Wire |
| Thu, Nov 12 | Q3 2009 ARYx Therapeutics Earnings Release - Time Not SuppliedCCBN |
| Thu, Nov 12 | ARYX THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EEDGAR Online |
| Thu, Nov 5 | ARYx Therapeutics Schedules Third Quarter 2009 Results Conference CallBusiness Wire |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.